Maurie Markman, MD

This report highlights 5 abstracts relevant to the current and future management of patients with female pelvic malignancies.

The desire to reduce the risk and severity of treatment-related toxicity by rapidly discontinuing ineffective therapy, and the increasing use of highly sensitive imaging technology.

The oncology community is quite conversant with the clinical utility of prognostic tumor markers.

Which studies should influence how I manage my patients and what criteria should I use to make these decisions?

Abstracts presented at the 2011 ASCO Annual Meeting will have a major impact on both standard-of-care disease management and the future of clinical trials in multiple settings.

Despite the importance of the recently enacted federal healthcare law, a remarkable 50% of the public does not know its current status.

Despite misgivings among physicians, the Internet is growing as a source of health information for patients.

Healthcare professionals in many specialties, particularly oncology, have long wrestled with the complexities and costs of integrating electronic medical records

Dr. Markman on HPV Testing to Detect Cervical Cancer

Dr. Markman Discusses the Swedish PSA Screening

Dr. Markman Discusses the Olaparib Phase II Trial

Dr. Markman Discusses the Importance of Cancer Screening

Dr. Markman on Taxane-Induced Neuropathy Biomarkers

The brave, (relatively) new world of social networking has presented even the medical community with challenges, but with a few precautions fellows can avoid some of the pitfalls associated with an online presence.

The genuine revolution in our understanding of the genetic basis of malignant disease has led to a corresponding interest in defining the risk of developing a particular disease for both individuals and specific populations.

It was not so long ago that designing an optimal treatment plan for an individual cancer patient required only a confirmed histologic/morphologic diagnosis of a particular tumor type and appropriate staging, which was surgically based in most solid tumors.

The Internet has been employed in a variety of interesting ways to foster clinical or research agendas.

Electronic communication technologies have radically changed our world, transforming almost every aspect of our daily lives. Most of the tasks we need to perform can be handled electronically, from paying bills and shopping to communicating with friends and family.

The websites and other resources your patients find on the Internet may downplay or ignore clinical evidence that herbal supplements may promote tumor growth or impair the effectiveness of established cancer treatments.